Complex assay tools such as reporter based
cis and trans activation systems are being developed
for screening several therapeutic targets. Further,
we are developing
a panel of reporter based functional assays to simultaneously
monitor key transcription factors downstream of receptor activated signaling
pathways. We will use this panel to simultaneously profile the activity
of a panel of 30+
GPCRs as well as other receptors to better
understand cellular cross-talk and predict side effects. This system can
also help
identify the molecular
mechanism of action of NCEs for which cell based or in vivo activity has
been established. The yeast group creates human disease models by knocking
out native yeast genes using homologous recombination and complementing
the phenotype with human homologues. Yeast is also used for other specialized
applications such as two hybrid screens. One new thrust area is the development
of a yeast growth assay
with genetically modified strains to assay those human targets that have
been refractory to HTS based approaches. Our gene expression team amplifies genes from a large panel of human lines and clones them into vectors appropriate for specific applications. We use a variety of host systems for expression - bacterial, yeast, insect and mammalian. SPECIAL MOLECULAR TOOLS - Reporter based transactivation for Nuclear Hormone Receptors and key Signal Transduction Nodes, RNA interference
Monitoring the level of SOD1 and SOD2 in complemented KO strains AMPLIFICATION, CLONING AND EXPRESSION |